Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases
Clinical trial NCT06224738 · UNKNOWN
Trial details
- NCT number
- NCT06224738
- Sponsor
- First People's Hospital of Hangzhou
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.